StockComparison Logo
vs

EHAB vs RLMD

Comparison between Enhabit, Inc. (EHAB, Company) and Relmada Therapeutics Inc (RLMD, Company).

Both EHAB and RLMD are from the Healthcare sector.

EHAB vs RLMD - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
EHAB
$707M
RLMD
$706M
Max Drawdown
Winner
EHAB
71.33%
RLMD
99.66%
Sharpe Ratio
EHAB
0.76
Winner
RLMD
2.36
5Y Beta
EHAB
N/A
RLMD
0.84
Industry
EHAB
Medical Care Facilities
RLMD
Biotechnology
P/E Ratio
EHAB
13.15
Winner
RLMD
-6.39
Forward P/E
EHAB
23.75
RLMD
N/A
5Y EPS CAGR
EHAB
N/A
RLMD
-0.59%
Debt to Equity
EHAB
0.00%
RLMD
0.00%
Free Cash Flow Yield
Winner
EHAB
11.45%
RLMD
-6.06%

EHAB vs RLMD - Historical Returns

Returns include dividend reinvestment.

1M
EHAB
-1.00%
Winner
RLMD
+6.15%
3M
Winner
EHAB
+23.66%
RLMD
+8.37%
6M
Winner
EHAB
+70.58%
RLMD
+62.17%
1Y
EHAB
+30.43%
Winner
RLMD
+861.57%
5Y(CAGR)
EHAB
N/A
RLMD
-26.28%
10Y(CAGR)
EHAB
N/A
RLMD
-4.83%
Max(CAGR)
Winner
EHAB
-12.11%
RLMD
-17.11%

EHAB vs RLMD - Annual Returns (2014 - 2026)

Returns include dividend reinvestment.

YearEHABRLMD
2026+51.82%+54.00%
2025+18.97%+973.09%
2024-23.13%-88.10%
2023-20.51%+23.21%
2022-42.13%-85.26%
2021N/A-31.69%
2020N/A-17.98%
2019N/A+747.83%
2018N/A+64.29%
2017N/A-31.82%
2016N/A-56.40%
2015N/A-84.13%
2014N/A+2.65%

EHAB vs RLMD Drawdown Comparison

The maximum drawdown for EHAB was -71.33%, occurring on Aug 1, 2025. This drawdown has not yet recovered.

The maximum drawdown for RLMD was -99.66%, occurring on Apr 8, 2025. This drawdown has not yet recovered.

The current EHAB drawdown is -39.31%. The current RLMD drawdown is -90.95%.

RankEHABRLMD
#1-71.33%
Jul 1, 2022 - Aug 1, 2025
-99.66%
Mar 16, 2015 - Apr 8, 2025
#2N/A-30.17%
Oct 31, 2014 - Mar 16, 2015
#3N/A-3.23%
Oct 10, 2014 - Oct 29, 2014

Correlation

Correlation between EHAB and RLMD is 0.56 which considered as a moderate positive correlation - the stocks show some tendency to move together.

0.56
-101

Select Stocks to Compare